SEC Form 4 · accession 0000930413-15-000225
ENZO BIOCHEM INC · ENZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elazar Rabbani
Officer — CEO, Chn. of the Brd. and Sec. · Director
Period of report
Jan 21, 2015
Accepted (ET)
Jan 23, 2015 · 4:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000316253
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (to acquire common stock)F1 | $3.40 | Jan 21, 2015 | A | 45,615 | A | Jan 22, 2016 | Jan 20, 2020 | Common Stock | 45,615 | 87,249 | D |
Explanation of responses
- F1The Reporting Person was granted 45,615 stock options. The options have a five-year term and shall vest in two equal annual installments, beginning January 22, 2016.